跳至主要内容
临床试验/NCT02835664
NCT02835664已完成不适用

Effects of Nicotinamide Riboside on Metabolic Health in (Pre)Obese Humans

Maastricht University Medical Center1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2016年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
Insulin sensitivity: muscle- and liver specific

研究概览

简要总结

This study will investigate the effects of 6 week Nicotinamide Riboside supplementation (1000 mg/day) on metabolic health in healthy (pre)obese humans. The primary objective will be hepatic and whole body insulin sensitivity. Secondary objectives, to provide information about the underlying mechanism, will be muscle mitochondrial function, brown fat activity, ectopic lipid accumulation, energy metabolism, cardiovascular risk parameters, body composition and acetylcarnitine levels.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent
  • Caucasian
  • Males and postmenopausal females
  • Aged 45-65 years at start of the study
  • Body mass index (BMI) 27 - 35 kg/m2
  • Stable dietary habits (no weight loss or gain >5kg in the past 3 months)
  • Sedentary lifestyle (not more than 2 hours of sports per week)

排除标准

  • Type 2 diabetes
  • Active diseases (cardiovascular, diabetes, liver, kidney, cancer or other)
  • Contra-indication for MRI
  • Participation in earlier research or medical examination that included PET/CT scanning
  • Alcohol consumption of >2 servings per day
  • Smoking in the past 6 months

结局指标

主要结局

Insulin sensitivity: muscle- and liver specific

时间窗: 6 weeks after supplementation

Hyperinsulinemic euglycemic clamp: Rate of glucose disappearance (Rd) will be calculated by using tracer kinetics.

次要结局

  • Body composition(6 weeks after supplementation)
  • Muscle mitochondrial function (ex vivo)(6 weeks after supplementation)
  • Ectopic lipid accumulation(6 weeks after supplementation)
  • Brown adipose tissue activity(6 weeks after supplementation)
  • Cardiovascular risk parameters(6 weeks after supplementation)
  • Whole body energy expenditure(6 weeks after supplementation)
  • Acetylcarnitine levels(6 weeks after supplementation)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验